Beranda › Kanker Rektum › Illinois
Uji klinis Kanker Rektum di Illinois
12 studi untuk Kanker Rektum mencari peserta di lokasi di Illinois.
Kota di Illinois
- Chicago8 studi
- Waukegan3 studi
- Aurora3 studi
- Danville3 studi
- Champaign3 studi
- Charleston3 studi
- Naperville3 studi
Teks studi resmi (Bahasa Inggris)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- OSF Saint Anthony's Health Center, Alton
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- dan 31 lainnya
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07283939Family Communications After Genetic Testing
- OSF Saint Anthony's Health Center, Alton
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- dan 46 lainnya
Menerima pesertaSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Endeavor Health ( Site 2027), Evanston
- Accellacare of Duly ( Site 2015), Lisle
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT06997497PRE-ISPY Phase I/II Oncology Platform Program
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
- UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
- UChicago Medicine Orland Park, Orland Park
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT05868226Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- OSF Saint Anthony's Health Center, Alton
- John H Stroger Jr Hospital of Cook County, Chicago
- Loyola University Medical Center, Maywood
- dan 3 lainnya
Menerima peserta
Usia 45 hingga 70 · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT05080673Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
- Rush-Copley Medical Center, Aurora
- Northwestern University, Chicago
- Carle at The Riverfront, Danville
- dan 6 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06205485Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- City of Hope at Illinois Chicago Downtown, Chicago
- City of Hope at Chicago, Zion
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Jul 2026 · NCT07595874Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal Cancer
- The University of Chicago, Chicago
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 15 Jun 2026 · NCT05943210A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Illinois Cancer Specialists, Arlington Heights
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT07011576Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 49 · Semua jenis kelamin · Diperbarui 24 Apr 2026 · NCT05732623SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.